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ABSTRACT
In neural stem cells (NSCs), the balance between
stem cell maintenance and neuronal differentiation
depends on cell-fate determinants such as TRIM32.
Previously, we have shown that TRIM32 associates
with the RNA-induced silencing complex and in-
creases the activity of microRNAs such as Let-7a.
However, the exact mechanism of microRNA regu-
lation by TRIM32 during neuronal differentiation has
yet to be elucidated. Here, we used a mass spectrom-
etry approach to identify novel protein–protein inter-
action partners of TRIM32 during neuronal differen-
tiation. We found that TRIM32 associates with pro-
teins involved in neurogenesis and RNA-related pro-
cesses, such as the RNA helicase DDX6, which has
been implicated in microRNA regulation. We demon-
strate, that DDX6 colocalizes with TRIM32 in NSCs
and neurons and that it increases the activity of Let-
7a. Furthermore, we provide evidence that DDX6 is
necessary and sufficient for neuronal differentiation
and that it functions in cooperation with TRIM32.
INTRODUCTION
Neural stem cells (NSCs) have the ability to either self-
renew or to give rise to different neural lineages, including
neurons, astrocytes and oligodendrocytes (1). The process
of generating functional neurons from NSCs is called neu-
rogenesis. Neurogenesis occurs at a high level during mouse
embryonic brain development, with NSCs giving rise to all
the neurons of the central nervous system (2). In the adult
brain, neurogenesis is restricted to two neurogenic niches:
the subventricular zone of the lateral ventricles and the sub-
granular zone of the hippocampus (1). It has been shown
that neurogenesis is not only relevant for brain function in
mice (3) but also occurs in the adult brains of songbirds (4),
monkeys (5) and humans (6–8).
The progression from NSCs to mature neurons is tightly
regulated by various signaling pathways and a complex
interplay of protein-coding and non-coding RNAs. One
highly conserved class of non-coding RNAs are microR-
NAs (miRNAs), which are endogenously encoded, short
(20–24 nt), single-stranded RNA molecules that post-
transcriptionally regulate gene expression (9,10). To per-
form their regulatory functions, miRNAs are incorporated
into the RNA-induced silencing complex (RISC), the ma-
jor components of which areArgonaute proteins (Ago).Mi-
croRNAs guide RISC to target mRNAs by complementary
base-pairing with their 3′ untranslated regions (3′ UTRs)
to mediate translational repression, mRNA degradation or
cleavage (11–13).
During neuronal differentiation,miRNAs are temporally
and spatially expressed and act as important regulatory
switches that control the balance between stem cell main-
tenance and neuronal differentiation (14–16). Many miR-
NAs are specifically enriched within the mammalian brain,
where they not only exert global effects such as the induc-
tion of neuronal differentiation but also function locally at
the growth cone or at synapses (17). Furthermore, altered
miRNA function or expression inNSCs has been associated
with several neurological disorders, such as Parkinson’s or
Alzheimer’s disease (18,19).
One key regulator of neuronal differentiation is the Let-
7 family of microRNAs, which is highly conserved across
species in both sequence and function (20). Let-7 members
become upregulated during mouse brain development and
their expression levels dramatically increase upon neuronal
differentiation of NSCs (20,21). Consistent with this, over-
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expressing the Let-7 family member Let-7a in NSCs has
been shown to promote neuronal differentiation, whereas
Let-7a inhibition preserves their NSC fate (22). The dy-
namic expression pattern ofmiRNAs necessitates their tight
regulation during the course of differentiation.However, lit-
tle is known about the upstream regulators of miRNAs.
One of the regulators of Let-7a activity is the neuronal
cell-fate determinant TRIM32 (22). TRIM32 belongs to the
TRIM-NHL family of proteins that is characterized by the
presence of anN-terminal RINGfinger, one or twoB boxes,
a coiled-coil region and a C-terminal NHL domain (23).
This conserved protein family has been implicated in di-
verse biological processes, such as developmental timing,
cell cycle progression, transcriptional regulation, apopto-
sis and signaling pathways (24). Previously, we have shown
that TRIM32 suppresses proliferation and induces neu-
ronal differentiation in NSCs of the embryonic (22,25,26)
and adult mouse brain (27), as well as muscle differentia-
tion in adult muscle stem cells (28). TRIM32 exerts its ef-
fect via twomechanisms. Through itsN-terminalRINGfin-
ger, TRIM32 ubiquitinates the transcription factor c-Myc,
thereby targeting it for proteasomal degradation and induc-
ing cell-cycle exit (22,25,29). Additionally, through its C-
terminal NHL domain, TRIM32 directly binds the RISC
protein Ago1, which leads to enhanced activity of spe-
cific microRNAs including Let-7a (22). However, the ex-
act mechanism by which TRIM32 regulates microRNAs to
promote neuronal differentiation remains elusive.
Interestingly, TRIM-NHL proteins have also been de-
scribed as RISC cofactors during the regulation of cell fate
choices in other species, such asDrosophila andCaenorhab-
ditis elegans (30,31). Similar to its mammalian homolog
TRIM32,C. elegansNHL-2 has been shown to enhance the
activity of the Let-7 family of microRNAs during progeni-
tor cell differentiation (31). NHL-2 colocalizes and directly
interacts with the RNA helicase CGH-1 and this interac-
tion is thought to be responsible for the enhanced activity
of associated microRNAs (31,32).
Here, we used a mass spectrometry approach to identify
novel potential TRIM32-associated proteins that may play
a role during neuronal differentiation. By applying bioin-
formatics tools, we identified an enrichment of proteins in-
volved in neurogenesis and RNA-related processes among
the potential TRIM32-associated proteins. One candidate
discovered in this screen was the RNA helicase DDX6,
which is the mammalian homolog of CGH-1 (33,34). We
demonstrate, that also in the mammalian system, TRIM32
andDDX6 colocalize inNSCs and neurons and thatDDX6
regulates the activity of the microRNA Let-7a. Consistent
with these data, overexpression of DDX6 in NSCs leads
to an increase in neuronal differentiation, whereas loss of
DDX6 function inhibits the generation of new neurons. Be-
cause this inhibition is even more pronounced in the ab-
sence of TRIM32, we conclude that both proteins coop-
erate during the induction of neuronal differentiation in
NSCs. Furthermore, both effects of DDX6, the stimulation
of Let-7a activity and the induction of neuronal differen-
tiation, appear to depend on its helicase activity. In sum-
mary, we present here a novel protein–protein interaction
network centered on the RNA-regulating proteins TRIM32
and DDX6, which is involved in the process of NSC differ-
entiation.
MATERIALS AND METHODS
Reagents and plasmids
For immunolabeling and protein biochemical methods, the
following antibodies were used: anti-TRIM32-3150 (Gram-
sch Laboratories), anti-TRIM32-3149 (Gramsch Labo-
ratories), anti-TRIM32-M09 (Abnova), anti-TRIM32-GS
(Genescript), anti-TRIM32-1137 (Gramsch Laboratories)
(25,27,28), anti-DDX6 (Abcam), anti-Ago2/eIF2C2 (Ab-
cam), anti-Ago2 (Sigma), anti-Pumilio1 (anti-Pum1) (Ab-
cam), anti-FLAG M2 (Sigma), anti-glyceraldehyde 3-
phosphate dehydrogenase (anti-GAPDH) (Abcam), anti-
enhanced green fluorescent protein (anti-EGFP) (Abcam),
anti-Sox2 (Abcam), anti-Ki67 (BD Pharmingen), anti-
phospho-Histone 3 (anti-PH3) (Millipore), anti-Tuj1 (Cov-
ance), anti-MAP2 (Millipore), anti-GFAP (Millipore) and
anti-S100 (Sigma). Alexa-fluorophore-conjugated anti-
bodies (Invitrogen) and horseradish peroxidase-coupled an-
tibodies (GE Healthcare) were used as secondary antibod-
ies for immunofluorescence staining and for immunoblot-
ting, respectively. DNA was counterstained using Hoechst
33258 (Invitrogen).
The following plasmids were used: pEGFP-N1 (Clon-
tech Laboratories), pEGFP-TRIM32 (23), pIRESn
eo-FLAG/HA-EGFP, pIRESneo-FLAG/HA-Ago1,
pIRESneo-FLAG/HA-Ago2, pIRESneo-FLAG/HA
-Ago3 and pIRESneo-FLAG/HA-Ago4-FLAG-HA,
pcDNA3.1D-Firefly-Let-7a with four perfectly
matched Let-7a binding sites (Let-7a-Sensor),
pcDNA3.1D-Firefly-Let-7a-mut with mismatches in the
Let-7a binding sites (Mut-Let-7a-Sensor), pcDNA3.1D-
Let-7a-1 (all kindly provided by Dr Sven Diederichs);
Venus1C-FLAG-DDX6 (kindly provided by Dr Dirk H.
Ostareck); pFLAG-CMV2-DDX6 (kindly provided by Dr
Masayuki Matsushita) and pEYFP-DDX6-EQ (kindly
provided by Dr Stanley M. Lemon).
DDX6 knockdown was achieved with the commer-
cially available shRNA-expression vectors pGFP-V-RS-D
DX6-shRNA3 (AAGAGCCTGTATGTGGCAGAATAC
CACAG) (Origene). The same vector expressing a scram-
bled (scrbl.) sequence (GCACTACCAGAGCTAACTCA
GATAGTACT) was used as a control (Origene).
Mice
TRIM32−/−mice were obtained from theMutant Mouse
Regional Resource Centers (MMRRC) (https://www.
mmrrc.org/catalog/sds.php?mmrrc id=11810/011810.html)
(27). For all mice, breeding, maintenance and experimental
procedures were performed in accordance with the German
Federal law on the Care and Use of laboratory animals.
Cell culture
Primary NSCs were isolated from single TRIM32 +/+ and
TRIM32 −/− mouse brains at embryonic day (E) 12.5–
14.5. NSCs were cultivated as neurospheres on uncoated
polystyrene tissue culture dishes in DMEM/Ham’s F12
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medium (PAA) supplemented with 10 ng/ml EGF (Pepro-
tech), 10 ng/ml bFGF-2 (Peprotech), 1× N2 (Invitrogen),
L-Glutamine (PAA) and Penicillin/Streptomycin (PAA).
For splitting, neurospheres were collected by centrifugation
for 3 min at 900 rpm and mechanically dissociated into sin-
gle cells by resuspending in maintenance medium. For im-
munocytochemical staining, neurosphereswere seeded onto
coverslips coated with poly-ornithine (Sigma) and Laminin
(Sigma).
Neuronal differentiation was induced by exchanging
50% of the maintenance medium with DMEM/Ham’s
F12 medium (PAA) supplemented with 10 ng/ml bFGF-
2 (Peprotech), 1× N2 (Invitrogen), 1× B27 (Invitrogen),
L-Glutamine (PAA) and Penicillin/Streptomycin (PAA).
For glial differentiation, the medium was changed com-
pletely to DMEM/Ham’s F12 medium (PAA) supple-
mented with 1× N2 (Invitrogen), 1% heat-inactivated
foetal calf serum (FCS) (PAA), L-Glutamine (PAA) and
Penicillin/Streptomycin (PAA). Differentiation was in-
duced for 5 days, after which cells were processed for im-
munocytochemical staining.
Neuroblastoma (N2a) cells, HEK293T cells andNIH3T3
cells were cultivated on uncoated 10-cm polystyrene tis-
sue culture dishes in DMEM (Sigma) supplemented with
10% heat-inactivated FCS (PAA), L-Glutamine (PAA) and
Penicillin/Streptomycin (PAA). For transfection, N2a cells
were seeded onto poly-ornithine-coated 6-well polystyrene
tissue culture plates 1 day prior to transfection, whereas
HEK293T cells were seeded onto poly-D-Lysine-coated
(Sigma) 10-cm polystyrene tissue culture dishes and
NIH3T3 cells were seeded onto poly-D-Lysine-coated cov-
erslips.
Transfection
Neurospheres were electroporated with 7.5 g of the indi-
cated plasmids using the Amaxa mouse NSC Nucleofector
Kit (Lonza) and theAmaxaNucleofector IIDevice (Lonza)
according to the manufacturer`s instructions.
N2a, HEK293T and NIH3T3 cells were transfected us-
ing Turbofect (Fermentas) according to the manufacturer’s
instructions. Each transfection experiment was repeated at
least three independent times.
Immunoprecipitation and western blot
For immunoprecipitation assays, HEK293T cells were lysed
48 h after transfection with lysis buffer (2% Triton X-100
and Complete protease inhibitor cocktail (PIC) (Roche) in
phosphate-buffered saline (PBS)) for 30 min at 4◦C. The
cell lysates were centrifuged for 30 min at 13 000 rpm at
4◦Cand the protein concentrations of the supernatants were
determined using a bicinchoninic acid (BCA) protein as-
say kit (Thermo Scientific) according to the manufacturer’s
instructions. After adjustment to equal protein concentra-
tions, a fraction of the lysate was mixed with sample buffer
and boiled at 95◦C for 5 min. The remaining cell lysate was
incubated with the precipitating antibody for 4 h at 4◦C and
then overnight with protein-G agarose beads (GE Health-
care). To digest endogenousRNAs usingmicrococcal nucle-
ase, beadswere resuspended in 100l lysis buffer containing
1mMCaCl2 and 600Umicrococcal nuclease and incubated
for 10min at RT. As an alternative approach, beads were in-
cubated with 10 g of RNAse A (Invitrogen) for 30 min at
4◦C. Bound proteins were eluted by boiling the samples for
15 min at 95◦C in protein sample buffer. The beads were
centrifuged for 5 min at 13 000 rpm and the supernatant
was subjected to sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) and western blotting.
For immunoprecipitation assays from brain tissues,
E10.5–E14.5 or adult mouse brains were lysed for 1 h at
4◦C in lysis buffer (2% Triton X-100 and PIC in PBS) that
was supplemented with 120 g/ml RNAse A and 6 g/ml
DNAse to reduce non-specific binding. The lysates were
immunoprecipitated as described above. To further reduce
non-specific binding, beads were pre-blocked for 1 h at 4◦C
with 1% BSA (Fraction V) (Roth) in PBS. All immunopre-
cipitation experiments were repeated at least three indepen-
dent times.
For immunoblot analysis, IP samples and lysates were
size-separated by electrophoresis on 4–12% NuPAGE Bis-
Tris gradient gels according to the manufacturer’s instruc-
tions (Invitrogen). After transfer to nitrocellulose mem-
branes, equal loading of the blotted protein was verified
by Ponceau S (Sigma) staining. Subsequently, membranes
were blocked for 1 h at RT in 5% skimmed milk pow-
der and 0.2% Tween in PBS before incubating overnight at
4◦C with the primary antibodies. Horseradish peroxidase-
conjugated secondary antibodies and enhanced chemilumi-
nescence reagents (ECL kit) (GE Healthcare) were used for
detection. Western blots were analyzed using ImageJ soft-
ware.
Immunocytochemistry
For immunocytochemical staining, cells were fixed with 4%
paraformaldehyde in 120 mM PBS, pH 7.4 (4% PFA/PBS)
followed by permeabilization for 3 min using 0.05% Triton
X-100 in PBS. Next, cells were blocked with 10% FCS in
PBS for 1 h at RT and subjected to immunofluorescence
staining with primary and secondary antibodies diluted in
blocking solution.
For cell counting, images were collected on a Zeiss epi-
fluorescence microscope, whereas for colocalization anal-
ysis, images were collected using a Zeiss confocal micro-
scope. Image analysis was performed using ZEN lite (Zeiss),
Adobe Photoshop and ImageJ software. Colocalization
analyses were conducted using the ImageJ Plugin JACoP
as described previously (35).
Luciferase assays
The activity of the microRNA Let-7a was determined us-
ing the LuciferaseAssay System (Promega) according to the
manufacturer’s instructions. Briefly, N2a cells were trans-
fected with 4 g of DNA in 6-well tissue culture plates.
Each transfection was performed twice with either the
Let-7a-Sensor or theMut-Let-7a-Sensor (36) cotransfected
with pcDNA3.1D-Let-7a-1 and an empty vector, EGFP,
TRIM32-EGFP-Myc, DDX6-FLAG, mutant DDX6-EQ-
EYFP, scrambled shRNA or DDX6 shRNA. After 72 h,
cells were lysed in Passive Lysis Buffer (Promega). Lumines-
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cencemeasurements were performed in quadruplicate in 96-
well plates containing 20l lysate per well. For each overex-
pression sample, the signal obtained from the WT-Let-7a-
Sensorwas normalized to that of themutant-Let-7a-Sensor.
Mass spectrometry analysis
Sample preparation. Stable cultures of NSCs were
generated as previously described (37). NSCs were
grown as monolayers under maintenance or neuronal-
differentiation-inducing conditions as previously described
(25). Cells were scraped in cold PBS containing PIC and
centrifuged for 5 min at 1100 rpm at 4◦C. The pellets from
22 10-cm dishes of proliferating cells and 25 10-cm dishes
of differentiated cells were pooled and centrifuged with
the identical settings. The resulting pellet was resuspended
in 4–5 pellet volumes of buffer A (10 mM Hepes pH 7.6,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM Dithiothreitol
(DTT), 1× PIC), mixed by inversion and incubated on
ice for 10 min before centrifuging for 10 min at 3000 rpm
at 4◦C. Whole-mouse brain tissue lysed in buffer A was
used as a negative control. The pellet was resuspended
in 2 pellet volumes of buffer A, homogenized using the
loose pestle (pestle A) of a Dounce homogenizer (20
strokes) and centrifuged for 10 min at 3000 rpm at 4◦C.
The supernatant was saved as the cytoplasmic fraction, the
pellet was centrifuged again for 1 min and the supernatant
was discarded. The pellet was resuspended in 1.5 pellet
volumes (volume from above) of buffer C (20 mM Hepes
pH 7.6, 20% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2
mM ethylenediaminetetraacetic acid (EDTA), 0.5 mM
DTT, 1 x PIC) homogenized using pestle B (20 strokes) of
a Dounce homogenizer, rotated using an overhead rotator
for 30 min at 4◦C and centrifuged for 15 min at 13 000
rpm. The supernatant contained the nuclear fraction. The
NaCl concentration of the nuclear fraction was adjusted
from 420 to 150 mM using H2O and the nuclear and
cytoplasmic fractions were incubated with the precipitation
antibody for 4 h at 4◦C (for TRIM32: 1137/3149 (Gramsch
Laboratories); for control: EGFP (Abcam)). A total of
100 l of protein-G Sepharose beads (GE Healthcare)
were washed four times in non-stick microcentrifuge tubes
(Alpha laboratories) with buffer C-100* (20 mM Hepes
pH 7.6, 20% glycerol, 100 mM KCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.02% NP40, 0.5 mM DTT, 1 x PIC) and 1.5
ml of the appropriate fraction was added. One twenty-fifth
volume of 25× PIC and 25 U/l Benzonase (Novagen)
were added and the samples were incubated on an over-
head shaker at 4◦C overnight. The next day, the beads were
washed five times with 700 l buffer C-100*. The bound
TRIM32 protein was eluted using equal amounts of two
TRIM32 peptides (1137: MESFTEEQLRPKLLH; 3149:
Cys-VKIYSYHLRRYSTP-COOH (Metabion)) diluted in
buffer C-100* at a total concentration of 0.2 mg/ml. A
total of four elutions were performed. For the first elution,
70 l of peptide was added, incubated for 30 min at 4◦C
and centrifuged for 2 min at 2000 rpm. A total of 65 l
of the supernatant was collected and centrifuged for 1
min at 2000 rpm to remove bead contamination. For the
second–fourth elution steps, 60 l of peptide was added to
the beads and the elution was performed as described for
elution 1. The fractions were pooled, and the proteins were
concentrated by TCA precipitation and analyzed by mass
spectrometry.
Mass spectrometry. The identification of proteins by mass
spectrometry was performed as previously described (38).
In summary, SDS-PAGE gel lanes were cut into slices and
subjected to in-gel reduction with dithiothreitol, alkyla-
tion with iodoacetamide and digestion with trypsin, essen-
tially as described by (39). Nanoflow LC-MS/MS was per-
formed on an 1100 series capillary LC system (Agilent Tech-
nologies) coupled to an LTQ-Orbitrap mass spectrometer
(Thermo) operating in positive mode and equipped with a
nanospray source. Peptide mixtures were trapped on a Re-
proSil C18 reversed phase column. Peptide separation was
performed on ReproSil C18 reversed phase column using a
linear gradient from 0 to 80% B (A = 0.1% formic acid; B
= 80% (v/v) acetonitrile, 0.1% formic acid) in 70 min and
at a constant flow rate of 200 nl/min using a splitter. The
column eluent was directly sprayed into the ESI source of
the mass spectrometer. Mass spectra were acquired in con-
tinuummode; fragmentation of the peptides was performed
in data-dependent mode. Peak lists were automatically cre-
ated from raw data files using the Mascot Distiller soft-
ware (version 2.1; MatrixScience). TheMascot search algo-
rithm (version 2.2, MatrixScience) was used for searching
against the NCBInr database (release NCBInr 20090222;
taxonomy: Mus musculus) or the IPI mouse database (re-
lease 20090924). The peptide tolerance was typically set to
10 ppm and the fragment ion tolerance to 0.8 Da. A max-
imum number of two missed cleavages by trypsin were al-
lowed and carbamidomethylated cysteine and oxidized me-
thioninewere set as fixed and variablemodifications, respec-
tively. The Mascot score cut-off value for a positive protein
hit was set to 60, based on at least two peptides. In case of
protein identifications with Mascot scores between 50 and
60, or that were based on only one peptide, individual pep-
tide MS/MS spectra were checked manually and either in-
terpreted as valid identifications or discarded.
Protein quantification. For both the differentiating and
proliferating NSC samples, the spectral counts of the re-
spective cytoplasmic and nuclear fractions were summed
prior to quantification. We identified 1950 proteins in the
differentiating NSC sample and 2266 proteins in the pro-
liferating NSC sample, whereas 29 proteins were identi-
fied in the negative control. In total, 2641 unique proteins
were identified in all samples. Proteins enriched in the NSC
samples versus the negative control were identified using
the one-sided Poisson significance test between the protein
spectral count of the negative control and the mean spec-
tral count of the two NSC samples. Given the relatively low
sample complexity, the missing spectral count was assumed
to be 0. Proteins with a P-value below 0.1 were consid-
ered significantly enriched in the NSC samples. The num-
ber of enriched proteins was 1407 at this significance level.
Of these, 1274 proteins were identified in both NSC sam-
ples, which were used in the next step to assess the differ-
ential abundance of potential TRIM32-associated proteins
between NSCs under maintenance conditions and after the
induction of neuronal differentiation. The proteins were
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binned by intensity (log2-transformed spectral count) and
the statistical significance was estimated in each bin with a
robust z-test. In each bin, the log2 ratio of protein spectral
counts was standardized and the z-score was computed af-
ter trimming the 2.5% outliers on both sides. The z-score of
the trimmed data points was extrapolated from the z-score
function. The z-score was then converted into the P-value.
Proteins with aP-value below 0.1 and an absolute log2 fold-
change above 0.5 were reported as differentially abundant
proteins. We identified 118 proteins, including TRIM32 it-
self, to be significantly more abundant under differentiation
conditions than under stem-cell-maintenance conditions. In
contrast, 79 proteins were more abundant in NSCs under
maintenance conditions.
Bioinformatic analysis. Gene Ontology Biological Pro-
cess was downloaded from http://www.geneontology.org.
Fisher’s exact test was performed to identify the statisti-
cal enrichment of Gene Ontology (GO) categories using
the 118 proteins that were more abundant in differentiating
NSCs as the test set. Proteins identified in the negative con-
trol, differentiating NSCs and/or proliferating NSCs were
taken as the background set. The P-value was corrected for
multiple testing by the Benjamini–Hochberg method. Cat-
egories with an adjusted P-value below 0.1 were defined as
significantly enriched. The mouse protein–protein interac-
tion data of the biological process GO terms ‘positive reg-
ulation of neurogenesis’ and RNA-regulation-related pro-
cesses were retrieved from MetaCore (GeneGo Inc. (40))
with the direct interactions algorithm. Non-physical inter-
action types such as ‘transcription regulation’ and ‘trans-
port’ were discarded. The networks were loaded in Cy-
toscape (41) and proteins enriched in the NSC samples, as
well as their first neighbors, were visualized.
RESULTS
Identification of DDX6 and Argonaute 2 as novel TRIM32
interaction partners
Previously, we have shown that the cell-fate determi-
nant TRIM32 induces neuronal differentiation in mouse
NSCs by increasing the activity of particular microRNAs
(22,25,27). Therefore, TRIM32 was an excellent starting
point to identify novel neurogenesis- and RNA-regulating
proteins. However, the exact mechanism of microRNA-
regulation by TRIM32 during neuronal differentiation has
yet to be elucidated. We therefore used a mass spectrometry
approach to identify novel interaction partners of TRIM32
in NSCs (38). To this end, TRIM32 was precipitated from
NSCs cultured undermaintenance conditions, as well as un-
der neuronal differentiation-inducing conditions (37) and
the proteins that coprecipitated with TRIM32 were ana-
lyzed bymass spectrometry (Figure 1a, Supplementary Fig-
ures S1 and S2, Supplementary Table S1). After filtering
for potential interaction candidates that were significantly
enriched in the NSC samples versus the negative control
(Supplementary Figure S1a), we performed a gene set en-
richment analysis of biological process GO terms of those
proteins that were significantly more abundant under dif-
ferentiation conditions than under stem-cell-maintenance
conditions (Supplementary Figure S1b–d; Supplementary
Table S2). Consistent with our previous results (22,25,27),
many potential TRIM32-interacting proteins were asso-
ciated with the term ‘positive regulation of neurogenesis’
(Supplementary Figure S1d and e; Supplementary Table S2;
Supplementary Table S3), underscoring the role of TRIM32
in neuronal differentiation. Interestingly, many GO cat-
egories associated with the regulation of RNA were en-
riched (Supplementary Figure S1d, Supplementary Figure
S2, Supplementary Table S2; Supplementary Table S3).
One interesting candidate identified by this approach is
the Argonaute 2 (Ago2) protein, which is part of RISC
(Figure 1a, Supplementary Figure S2, Supplementary Table
S1; Supplementary Table S3). Because we have already de-
scribed an interaction between TRIM32 and the Argonaute
1 protein (22), we extended our analysis to the entire family
ofAgo, which consists of fourmembers inmammals. There-
fore, we overexpressed FLAG-tagged Ago1-4 in HEK293T
cells and precipitated the proteins using an anti-FLAG an-
tibody. Using this approach, we were able to coimmuno-
precipitate TRIM32 together with Ago1, 2 and 3, but not
with Ago4 (Figure 1b). However, because only low expres-
sion levels of Ago4 were observed in the lysates (see aster-
isk in Figure 1b), any potential interaction with TRIM32
may have been undetectable. Given that our mass spectrom-
etry approach identified Ago2 as a potential TRIM32 in-
teraction partner in proliferating and differentiating NSCs
and because Ago2 has been well studied for its function in
post-transcriptional gene silencing, we focused on this fam-
ily member for the following experiments.
Another interesting candidate revealed by the mass spec-
trometry analysis is the RNA helicase DDX6 (Figure 1a,
Supplementary Figure S2, Supplementary Table S1; Sup-
plementary Table S3), whose C. elegans homolog CGH-1
was shown to interact with the TRIM32 homolog NHL-
2 (31). Overexpressed DDX6-Venus-FLAG in HEK293T
cells coimmunoprecipitated with TRIM32, confirming that
this interaction is conserved between the mammalian ho-
mologs (Figure 1c). Finally, the precipitation of overex-
pressed FLAG-tagged Ago2 from HEK293T cells showed
that Ago2 and DDX6 also form a complex (Figure 1d).
To determine whether these interactions occur directly or
are mediated by RNA, lysates were treated with Micrococ-
cal nuclease (MNase) or RNAse A prior to immunopre-
cipitation, leading to the preferential degradation of single-
stranded RNA. The different proteins were still able to bind
one another, albeit more weakly in the case of the interac-
tions between Ago2 and TRIM32 or DDX6 (Supplemen-
tary Figure S3a-c and data not shown). Therefore, we con-
clude that the interaction between TRIM32 and DDX6 is
RNA independent, while the interactions between Ago2
and TRIM32 as well as Ago2 andDDX6 are partially RNA
dependent.
To further investigate whether these interactions also oc-
cur in vivo, DDX6 was precipitated from mouse embryonic
brain lysates, which contain a large fraction of undifferenti-
ated NSCs. Using this approach, we were able to detect the
binding of both Ago2 and TRIM32 to DDX6 (Figure 2a),
suggesting that these proteins form a complex in vivo in the
embryonic brain. These interactions were found to persist
in the adult brain (Figure 2b) which primarily consists of
differentiated cells. Thus, TRIM32, Ago2 and DDX6 may
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Figure 1. Identification of Ago2 and DDX6 as novel TRIM32-associated proteins via mass spectrometry. (a) Scheme depicting the experimental design
of the mass spectrometry approach. TRIM32 was precipitated from NSCs either grown under maintenance conditions or 3 days after the induction of
neuronal differentiation using an anti-TRIM32 antibody. Proteins that coprecipitated with TRIM32 were analyzed by mass spectrometry, which identified
Ago2 and DDX6 as potential TRIM32 interaction partners (the full list of identified proteins is provided in Supplementary Table S1). (b) HEK293T
cells were transfected with the indicated constructs and the different FLAG-tagged Ago proteins were immunoprecipitated with an anti-FLAG antibody.
Ago-associated TRIM32 was detected with an anti-TRIM32 antibody. TRIM32 and FLAG-tagged Ago proteins were detected with specific antibodies as
indicated for the immunoprecipitation (IP) and the lysate. Note that although Ago4 was detectable after enrichment via precipitation, no Ago4-expression
could be detected within the lysate (asterisk). (c) HEK293T cells were transfected with the indicated constructs and Venus-FLAG-tagged DDX6 was
immunoprecipitated with an anti-FLAG antibody. DDX6-associated TRIM32 was detected with an anti-TRIM32 antibody. TRIM32 and Venus-FLAG-
taggedDDX6were detected with specific antibodies as indicated for the IP and the lysate. (d) HEK293T cells were transfected with the indicated constructs
andFLAG-taggedAgo2was immunoprecipitatedwith an anti-FLAGantibody. Ago2-associatedDDX6was detectedwith an anti-DDX6 antibody.DDX6
and FLAG-tagged Ago2 were detected with specific antibodies as indicated for the IP and the lysate. In (b–d), GAPDHwestern blots were used as loading
control.
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Figure 2. TRIM32, Ago2 and DDX6 directly interact with each other in vivo. (a) Immunoblots of IPs from E10.5 to E14.5 embryonic brain lysates
using antibodies against DDX6 or GFP (negative control). DDX6, TRIM32 and Ago2 were detected with the indicated specific antibodies in the IP and
lysate. (b) Immunoblots of IPs from adult brain lysates using antibodies against DDX6, Ago2 or GFP (negative control). DDX6, TRIM32 and Ago2
were detected with the indicated specific antibodies in the IP and lysate. Abbreviations: EGFP, enhanced green fluorescent protein; Ago, Argonaute; IP,
immunoprecipitation; WB, western blot; Neg. Ctrl., negative control.
interact with one another in both undifferentiated and dif-
ferentiated cells. Interestingly, we also detected the binding
of all three proteins to the RNA-binding protein Pumilio
1 (Pum1) in vivo (Supplementary Figure S3d and e). Pum1
has recently been implicated in the regulation of mRNAs
via microRNAs inC. elegans (42), and inDrosophila, Pum1
has been shown to interact with the TRIM32 homolog Brat,
thereby increasing its activity (43). Finally, Pum1 was also
detected in our mass spectrometry analysis (Supplementary
Table S1), further underscoring the quality of the obtained
data.
TRIM32, DDX6 and Ago2 colocalize
To analyze the subcellular localization of TRIM32, DDX6
and Ago2, we first overexpressed the recombinant pro-
teins in NIH3T3 cells, which are well suited for localiza-
tion analysis because of their flatmorphology. All three pro-
teins exhibited diffuse staining throughout the cytoplasm
and were strongly enriched in cytoplasmic punctae (Sup-
plementary Figure S4). Interestingly, when overexpressing
TRIM32 and Ago2, TRIM32 and DDX6, or Ago2 and
DDX6, two different populations of cytoplasmic punctae
were observed: those in which both proteins colocalized
and those in which both proteins appeared to exclude each
other. However, whenmeasured over the entire cell, colocal-
ization was observed in each case (Supplementary Figure
S4).
To extend the colocalization analysis to the endogenous
proteins, we generated neurosphere cultures from E12.5–
E14.5 TRIM32 +/+ and −/− embryos and analyzed the
subcellular distribution of TRIM32, DDX6 and Ago2 un-
der maintenance and neuronal differentiation conditions.
Undermaintenance conditions, TRIM32,DDX6 andAgo2
localized to the cytoplasm of TRIM32 +/+ neurospheres
and were found to colocalize with each other (Figure 3a,
c–e, Supplementary Figure S5a and c). Under neuronal dif-
ferentiation conditions, nuclear translocation of TRIM32
was observed (Figure 3a, Supplementary Figure S5a and c),
consistent with our previous results (25,27). Interestingly,
also a pool of Ago2 translocated to the nucleus upon dif-
ferentiation, while DDX6 remained primarily in the cyto-
plasm (Figure 3a, Supplementary Figure S5a and c). How-
ever, all three proteins were also observed to colocalize un-
der these conditions (Figure 3c–e, Supplementary Figure
S5a and c). A similar distribution of Ago2 and DDX6 was
observed in TRIM32−/− neurospheres, with both proteins
localizing to the cytoplasm under maintenance conditions,
while a pool of Ago2 localized to the nucleus under neu-
ronal differentiation conditions (Figure 3b, Supplementary
Figure S5b and d). We did not detect any difference in the
degree of colocalization of DDX6 and Ago2 in the absence
or presence of TRIM32 (TRIM32 +/+ versus −/− cells)
(Figure 3e, Supplementary Figure S5b and d).
Neuronal differentiation is impaired in TRIM32 −/− NSCs
Because TRIM32 has been described as necessary for neu-
ronal differentiation in the embryonic (22,25) and adult
mouse brain (27), we investigated the differentiation poten-
tial of TRIM32 +/+ and −/− neurospheres. We first in-
vestigated neurospheres growing under maintenance con-
ditions. Almost all TRIM32 +/+ and −/− NSCs were pos-
itive for the NSC marker Sox2 (Figure 4a and b), indicat-
ing that the loss of TRIM32 has no effect on the mainte-
nance of stem cell fate in NSCs. However, in TRIM32 −/−
NSCs, a significant increase in the amount of mitotically
active (Ki67-positive) and dividing (PH3-positive) cells was
detected (Figure 4c–e), demonstrating that proliferation is
increased upon loss of TRIM32 under maintenance condi-
tions.
We then differentiated TRIM32 +/+ and−/−NSCs into
neurons for 5 days. At this time point,∼50%of the TRIM32
+/+ cells had upregulated the young neuronal marker TuJ1
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Figure 3. TRIM32, Ago2 and DDX6 colocalize in NSCs and neurons. (a and b) Immunostaining of neurospheres derived from TRIM32 +/+ (a) and
TRIM32 −/− (b) mice, cultured under maintenance conditions and 5 days after the induction of neuronal differentiation, with the indicated markers.
Single optical planes are shown. The right panels show a higher magnification of the boxed areas. Scale bars = 20 m; for high magnifications, 5 m. (c–e)
Diagrams showing Pearson’s coefficients for the colocalization of TRIM32 and Ago2 (c), TRIM32 and DDX6 (d) and Ago2 and DDX6 (e) in NSCs and
neurons. Colocalization was defined as a Pearson’s coefficient ≥0.3 (blue dotted line) (mean ± SEM; n ≥ 20 cells, N = 3 independent TRIM32 +/+ and
TRIM32 −/− neurosphere cultures).
and almost 32% had started to express the more mature
neuronal marker MAP2 (Figure 4f-h). In contrast, only 26
and 17% of the TRIM32 −/− cells had differentiated into
TuJ1- and MAP2-positive cells, respectively (Figure 4f–h).
In addition, the effect on proliferating cells became more
pronounced upon the induction of neuronal differentia-
tion. Whereas only a few proliferating cells were detected
among the TRIM32 +/+ cells 5 days after differentiation,
a strong increase in the amount of Ki67- and PH3-positive
cells was detected in the TRIM32 −/− cells (Figure 4i–k,
Supplementary Figure S6a). These results demonstrate that
neuronal differentiation in neurospheres is impaired follow-
ing the loss of TRIM32. Remarkably, the differentiation-
inducing potential of TRIM32 appears to be restricted to
the neuronal lineage, as indicated by the fact that glial dif-
ferentiation was unaffected upon loss of TRIM32 (Supple-
mentary Figure S6b–e).
DDX6 stimulates the activity of the microRNA Let-7a
We have previously shown that one of the mechanisms by
which TRIM32 induces neuronal differentiation is through
the activation of the microRNA Let-7a (22). Given that
the C. elegans homolog of DDX6 has also been implicated
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Figure 4. Absence of TRIM32 results in increased proliferation and reduced neuronal differentiation of NSCs. (a and c) Immunostaining of neurospheres
derived from TRIM32 +/+ and TRIM32 −/− mice cultured under maintenance conditions with the indicated markers. Scale bars = 20 m. (b, d and e)
Quantification of the percentage of TRIM32 +/+ and −/− NSCs positive for the NSC marker Sox2 (b), the proliferation marker Ki67 (d) and the mitotic
marker PH3 (e) (mean ± SEM; n ≥ 1200 cells, N = 4 independent TRIM32 +/+ and −/− neurosphere cultures; t-test, *P < 0.05 compared to TRIM32
+/+). (f and i) Immunostaining of neurospheres derived from TRIM32 +/+ and TRIM32 −/− mice 5 days after the induction of neuronal differentiation
with the indicated markers. Scale bars = 20 m. (g, h, j and k) Quantification of the percentage of TRIM32 +/+ and −/− neurons positive for the young
neuronal marker TuJ1 (g), the mature neuronal marker MAP2 (h), the proliferation marker Ki67 (j) and the mitotic marker PH3 (k) (mean ± SEM; n ≥
1400 cells, N ≥ 3 independent TRIM32 +/+ and −/− neurosphere cultures; t-test (TuJ1, MAP2, PH3), ***P < 0.005; Mann–Whitney U test (Ki67), *P
< 0.05 compared to TRIM32 +/+).
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in the regulation of the Let-7 family of microRNAs (31),
we sought to investigate whether mammalian DDX6 simi-
larly influences Let-7a activity. Therefore, luciferase assays
were performed using aLet-7a sensor encoding for firefly lu-
ciferase followed by Let-7a binding sites in the 3′ UTR (Fig-
ure 5a). Amutant Let-7a sensor that containsmismatches in
its seed region and can no longer be silenced by Let-7a bind-
ing was used as a control (Figure 5a). Each construct was
then transfected into neuroblastoma (N2a) cells together
with DDX6, TRIM32 or both. Consistent with previously
published data (22), the overexpression of TRIM32 led to
a strong decrease in the luciferase signal, demonstrating
the activation of Let-7a. DDX6 overexpression also signifi-
cantly stimulated Let-7a activity and this effect was further
enhanced upon coexpression of TRIM32 (Figure 5b).
We next asked whether DDX6 is necessary for Let-7a ac-
tivity. Therefore, N2a cells were transfected with shRNA
constructs containing either a scrambled sequence or a se-
quence targeting DDX6, which resulted in ∼50% knock-
down (Supplementary Figure S7a,b). Following knock-
downofDDX6, a significant increase in the luciferase signal
could be detected (Figure 5c), demonstrating that Let-7a ac-
tivity is decreased in the absence of DDX6.
To investigate whether the helicase domain of DDX6 is
required for activating Let-7a, we used a mutant DDX6
construct (DDX6-EQ) that contains a point mutation
within the DEAD box motif II of DDX6 and thus lacks he-
licase activity (44). Interestingly, the overexpression of this
mutant in N2a cells led to a significant increase in the lu-
ciferase signal, representing reduced Let-7a activity (Fig-
ure 5d). This effect was not due to a disruption of the inter-
action with TRIM32, as DDX6-EQ was nevertheless able
to coimmunoprecipitate TRIM32 (Supplementary Figure
S7c). These data indicate that DDX6 function is necessary
for the activation of Let-7a and that this effect depends on
its helicase activity.
DDX6 induces differentiation in NSCs
The fact that DDX6 is able to increase the activity of
the neuronal differentiation-inducing miRNA Let-7a (22)
suggests that DDX6 may play a role in the induction of
neuronal differentiation. This hypothesis was further sup-
ported by the observation that DDX6 is upregulated upon
neuronal differentiation of TRIM32 +/+ and −/− neuro-
spheres, particularly in cells with a neuronal morphology
compared to those with an astrocytic morphology. Indeed,
costaining ofDDX6with the neuronalmarker TuJ1 showed
a substantially stronger signal for DDX6 in TuJ1-positive
cells compared with TuJ1-negative cells (Figure 6).
Therefore, we sought to examine whether DDX6 has
the ability to induce neuronal differentiation in NSCs and
whether this is influenced by the presence or absence of
TRIM32. To address these questions, neurospheres ob-
tained from TRIM32 +/+ or −/− mice were nucleofected
with DDX6 or EGFP expression constructs. One day af-
ter nucleofection, cells were differentiated into neurons for
5 days. To assess the degree of neuronal differentiation, cells
were stained for the young neuronal marker TuJ1 as well as
the proliferation marker Ki67.
DDX6 overexpression in TRIM32 +/+ NSCs greatly in-
creased the amount of TuJ1-positive cells (78% of cells)
compared with the EGFP control transfection (34% of
cells) (Figure 7a and b, Supplementary Figure S8a). Con-
comitant with this increase, the amount of proliferating,
Ki67-positive cells was significantly decreased from 13 to
<6% under these conditions (Figure 7a and c, Supple-
mentary Figure S8a). When comparing the EGFP control-
transfected TRIM32 +/+ to −/− NSCs, the amount of
TuJ1-positive cells decreased to 22% and the amount of
Ki67-positive cells increased to 31% in TRIM32−/−NSCs
(Figure 7, Supplementary Figure S8a), consistent with our
previous results (Figure 4). Remarkably, overexpressing
DDX6 in TRIM32-deficient NSCs could partially rescue
this phenotype, resulting in an increase in the amount of
TuJ1-positive cells (54%) and a decrease in the amount of
Ki67-positive cells (14%), albeit to a lesser extent than in
TRIM32 +/+NSCs (Figure 7, Supplementary Figure S8a).
Therefore, DDX6 inhibits proliferation and induces neu-
ronal differentiation in NSCs in the presence and absence
of TRIM32. However, because DDX6 cannot fully rescue
the TRIM32 −/− phenotype, both proteins appear to be
required for proper neuronal differentiation.
Loss of DDX6 function inhibits the differentiation of NSCs
To further analyze whether DDX6 is required for neuronal
differentiation, we introduced our scrambled- or DDX6-
targeting shRNA constructs (Supplementary Figure S7a,b)
into TRIM32 +/+ and −/− NSCs by nucleofection. The
amount of TuJ1- and Ki67-positive cells was quantified 5
days after the induction of neuronal differentiation.
Knockdown of DDX6 in TRIM32 +/+ NSCs reduced
the amount of TuJ1-positive cells from 38% (control con-
ditions) to 24% and slightly increased the amount of Ki67-
positive cells (from 15 to 26%) (Figure 8a–c, Supplemen-
tary Figure S8b). This effect was even more pronounced,
when DDX6 was knocked down in TRIM32 −/− NSCs,
after which only 13% of electroporated cells still expressed
TuJ1 and 39% of cells expressed Ki67 (Figure 8a–c, Sup-
plementary Figure S8b). These results indicate that DDX6
and TRIM32 cooperate during the induction of neuronal
differentiation in NSCs.
We next sought to investigate whether the neuronal-fate-
inducing effect of DDX6 is dependent on its helicase ac-
tivity. Therefore, TRIM32 +/+ and -/- NSCs were electro-
porated with the helicase-deficient DDX6-EQ mutant. Be-
cause the DDX6-EQ mutant had a similar effect on neu-
ronal differentiation as the shRNA-mediated knockdown
of DDX6 (Figure 8, Supplementary Figure S8b, Supple-
mentary Figure S9), we conclude that the positive effect of
DDX6 on neuronal differentiation is mediated by its heli-
case activity.
DISCUSSION
In the present study, we provide evidence that the twoRNA-
regulating proteins TRIM32 and DDX6 cooperate in the
regulation of microRNAs to promote neuronal differenti-
ation. Using mass spectrometry and bioinformatics tools,
we identified a novel set of potential TRIM32-associated
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Figure 5. DDX6 induces the activity of the microRNA Let-7a. (a) Scheme depicting the luciferase sensors used in the luciferase assays. A Let-7a sensor
was used that encodes firefly luciferase followed by Let-7a binding sites in its 3′ UTR. Luciferase is expressed in the absence of Let-7a and its activity can
be measured via luciferase assays. In contrast, in the presence of Let-7a, luciferase expression is post-transcriptionally inhibited by binding of Let-7a to its
binding sites. A mutant Let-7a sensor that contains mismatches in its seed region and can no longer be silenced by Let-7a binding was used as a control.
(b) Diagram showing the normalized activity of Let-7a luciferase sensors coexpressed with Let-7a and TRIM32-EGFP, DDX6-FLAG or TRIM32-EGFP
and DDX6-FLAG in N2a cells (mean ± SEM; N = 10 independent experiments; Mann–Whitney U test, *P < 0.05, ***P < 0.005). (c) Diagram showing
the normalized activity of Let-7a luciferase sensors coexpressed with Let-7a and either scrambled (scrbl.) shRNA or DDX6-shRNA in N2a cells (mean ±
SEM; N = 4 independent experiments; Mann–Whitney U test, *P < 0.05 compared to scrambled shRNA). (d) Diagram showing the normalized activity
of Let-7a luciferase sensors coexpressed with Let-7a and EGFP or mutant DDX6-EQ-EYFP in N2a cells (mean ± SEM;N= 9 independent experiments;
t-test, **P < 0.01 compared to EGFP). (b–d) Note that a decrease in the luciferase signal reflects increased Let-7a activity and viceversa.
proteins involved in neuronal differentiation. As the main
purpose of this approach was to screen for novel potential
TRIM32 interaction partners, it was conducted only once
and interesting candidates were verified in additional as-
says. Nevertheless, the quality of our mass spectrometry ap-
proach is supported by the detection of several previously
reported TRIM32 interaction partners, including -actinin
and tropomyosin-1 (45), myosin (46), HIV Tat (47) as well
as UBE2N and UBE2V1 (29) (Supplementary Table S1).
However, all conclusion drawn from newly identified pro-
teins that were not verified in additional assays obviously
have a lower degree of confidence and remain to be con-
firmed.
Many of the potentially TRIM32-associated proteins
identified in the mass spectrometry analysis were associ-
ated with theGO term ‘positive regulation of neurogenesis’,
which is consistent with the well-described role of TRIM32
in promoting neuronal differentiation in the embryonic and
adult mouse brain (22,25,27). The importance of TRIM32
during neuronal differentiation is further highlighted by
the impaired neuronal differentiation potential that we ob-
served in TRIM32 −/− NSCs compared to TRIM32 +/+
NSCs.
Interestingly, we detected an enrichment of TRIM32-
associated proteins involved inRNA-related processes, such
as RNA stabilization or processing, consistent with the role
of TRIM32 as a RISC cofactor in microRNA-mediated
gene silencing during neuronal differentiation (22,48). In
addition, the RISC protein Ago2 was identified as one of
the TRIM32-associated proteins involved in RNA regula-
tion. We further extended our analysis to the entire family
of Ago and showed that TRIM32 can interact with Ago1,
2 and 3, but not with Ago4. However, only low levels of
Ago4 expression could be obtained using our approach,
suggesting that a potential interaction with TRIM32 may
have gone undetected. Nevertheless, the abundance of the
Ago4 protein is relatively low compared with the other Ago
family members in many different cell types (49), indicating
that it may play a minor role in microRNA-mediated gene
silencing.
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Figure 6. DDX6 is upregulated during neuronal differentiation in NSCs.Immunostaining of neurospheres derived from TRIM32 +/+ and TRIM32 −/−
mice 5 days after the induction of neuronal differentiation with the indicated markers. The right panels show single cells at higher magnification. Scale bar
= 20 m; for high magnifications, 10 m.
Given that Ago2 was identified as a candidate TRIM32
interaction partner in proliferating and differentiating
NSCs and given that Ago2 has been well studied for its
function in post-transcriptional gene silencing, as it is the
only catalytic Ago protein in mammals (50), we focused on
Ago2 in the subsequent experiments. We demonstrated that
TRIM32 and Ago2 interact in vivo in both the embryonic
and adult mouse brain, which contain large fractions of un-
differentiated NSCs and postmitotic neurons, respectively.
This result is consistent with the observed colocalization
of TRIM32 and Ago2 in NSCs and differentiated neurons,
further confirming that the interaction between these two
proteins is important in both proliferating and differentiat-
ing cells. Because both proteins associate with each other
in NSCs prior to the induction of neuronal differentiation,
these NSCs may already be primed to undergo differentia-
tion.
TRIM32 efficiently increased Let-7a activity, underscor-
ing its function as a RISC cofactor in the induction of neu-
ronal differentiation. Functioning as a RISC cofactor dur-
ing the regulation of cell fate determination appears to be a
common property of TRIM-NHL proteins. In Drosophila,
the TRIM-NHL protein Mei-P26 has been shown to asso-
ciate with RISC via Ago1, but in contrast to TRIM32,Mei-
P26 was shown to inhibit microRNA activity to regulate
proliferationwithin the germline (30). Brat, another TRIM-
NHL protein in Drosophila, binds Ago1 and functions to
post-transcriptionally inhibit Myc expression, thereby pro-
moting the differentiation of neuroblasts (51). Remarkably,
TRIM32 also regulates c-Myc protein levels, though in con-
trast to Brat, this is accomplished through the ubiquitina-
tion of c-Myc rather than through post-transcriptional gene
silencing, thereby targeting c-Myc for proteasomal degra-
dation (22,25). Interestingly, Myc has also been shown to
be a direct target of Let-7 (52), suggesting that TRIM32
can additionally silence c-Myc expression indirectly at the
post-transcriptional level. The fact that Myc also inhibits
Let-7 transcription implies that both function in a double-
negative feedback loop (52,53) that appears to be regu-
lated by TRIM32. Another TRIM-NHL protein that func-
tions in progenitor cell differentiation by regulating the mi-
croRNA Let-7 is NHL-2. In C. elegans, NHL-2 associates
with the Ago ALG-1 and -2 and enhances the activity of
the Let-7 family of microRNAs in concert with the RNA
helicase CGH-1 (31).
Interestingly, one of the TRIM32-associated proteins
identified by ourmass spectrometry analysis in proliferating
and differentiating NSCs was DDX6, the mammalian ho-
molog of CGH-1 (33,34). TRIM32 and DDX6 interact in
embryonic and adult mouse brains and colocalize in prolif-
erating and differentiating NSCs, suggesting that both pro-
teins function together during neuronal differentiation. We
further showed that also Ago2 and DDX6 directly interact
with each other both in vitro and in vivo and colocalize in
NSCs and in neurons, consistent with a previous report that
demonstrated the interaction between DDX6 and Ago1 as
well as Ago2 in human cells (54). These findings suggest,
that TRIM32, DDX6 and Ago2 form an miRNA activity-
regulating complex.
DDX6 is a member of the evolutionarily conserved fam-
ily of DEAD-box helicases that is characterized by the
presence of an Asp-Glu-Ala-Asp (DEAD) motif and has
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Figure 7. DDX6 is sufficient to induce neuronal differentiation in NSCs. (a) TRIM32 +/+ and −/− neurospheres were nucleofected with EGFP-FLAG
or DDX6-Venus-FLAG and differentiated into neurons for 5 days. Immunostaining of the cells labeled as indicated is shown. Overexpressed DDX6 shows
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been implicated in almost every aspect of RNAmetabolism
including transcription, splicing, translation, processing,
degradation and storage (55,56). DEAD-box helicases usu-
ally function as part of larger multicomponent complexes
and use ATP to unwind short RNA duplexes or to re-
model RNA–protein complexes (34,56). Several studies in-
dicated that DDX6 acts as a general translational repres-
sor in the regulation of mRNA translation in yeast, hu-
man as well as mouse hippocampal neurons (54,57–59).
DDX6 has thus been shown to associate with RISC and
to function in microRNA-mediated gene silencing (54). In
this context, recent publications reported a direct interac-
tion between DDX6 and CNOT1, the scaffold subunit of
the CCR4-NOT deadenylase complex (60–62). This inter-
action was found to stimulate the ATPase activity of DDX6
(61,62) and to be critical for miRNA-mediated gene silenc-
ing (60). Interestingly, CNOT1 as well as several poly(A)
binding proteins have been identified in our mass spectrom-
etry analysis (Supplementary Table S1).
Consistent with these findings, we demonstrated that the
overexpression of DDX6 leads to a significant increase
in Let-7a activity. This effect was further enhanced by
TRIM32 coexpression, similar to the C. elegans homologs
NHL-2 and CGH-1 (31). These data suggest that both
TRIM32 and DDX6 are able to increase the activity of Let-
7a. Furthermore, DDX6 is also required for Let-7a activ-
ity, as knockdown of DDX6 abolished Let-7a activity, con-
sistent with a previous report showing that the depletion
of DDX6 released microRNA-mediated gene silencing in
human cells (54). Remarkably, a mutant DDX6 construct
(DDX6-EQ), which lacks helicase activity due to a point
mutation within the DEAD box motif II of DDX6 (44),
also strongly decreased Let-7a activity. The fact that mu-
tant DDX6 not only fails to activate Let-7a but also in-
hibits its activity suggests that this mutant functions in a
dominant-negative manner, as has been described during
hepatitis C viral replication (44). As was shown for the in-
teraction of DDX6-EQ with viral proteins (44), the DDX6
EQ-mutation did not abolish the interaction with TRIM32,
demonstrating that the helicase activity is necessary for ac-
tivating Let-7a.
Consistent with its role in the repression of mRNA trans-
lation,DDX6 has been described as an essential component
of P-bodies, which are cytoplasmic foci containing transla-
tionally repressed mRNAs. Interestingly, DDX6, TRIM32
and to a lesser extent Ago2 were strongly enriched in cy-
toplasmic punctae when overexpressed in NIH3T3 cells, as
well as in vivo in NSCs and neurons. Notably, two differ-
ent populations of these punctae were observed, those in
which TRIM32 and Ago2, TRIM32 and DDX6 or Ago2
and DDX6 colocalized, and those in which the different
proteins excluded one another. Some of these cytoplasmic
punctae may represent P-bodies, as it has been shown that
DDX6 andAgo2 colocalize in P-bodies in human cells (63),
as do CGH-1 (C. elegans DDX6) and NHL-2 (C. elegans
TRIM32) in neuronal and hypodermal cells in C. elegans
(31,54). Because RISC colocalizes with P-bodies, they were
proposed to be the sites where target mRNAs are repressed
or degraded by RISC (63,64). However, the translational
repression of mRNAs by microRNAs nevertheless occurs
following the disruption of P-bodies, suggesting that effi-
cient post-transcriptional gene silencing does not require P-
bodies (54). Furthermore, it was shown that the microRNA
Let-7 inhibits translation at the initiation step in the cy-
toplasm, indicating that repressed mRNAs localize to P-
bodies for storage as a consequence rather than a cause of
repression (65). Because TRIM32, DDX6 and Ago2 also
showed diffuse cytoplasmic staining, they may form a com-
plex in the cytoplasm to regulate microRNA-mediated gene
silencing, after which the inhibited target mRNAs are sub-
sequently stored in P-bodies, a process that may not require
the combined action of all three proteins.
Interestingly, we observed the upregulation of DDX6
in differentiating neurons but not in astrocytes. Further-
more, because we were able to demonstrate that DDX6 sig-
nificantly increases the activity of Let-7a, one of the key
regulators of neuronal differentiation, we speculated that
DDX6 may function to promote neuronal differentiation.
Indeed, overexpression of DDX6 in NSCs strongly induced
their differentiation into neurons. This effect was less pro-
nounced in the absence of TRIM32, suggesting that both
proteins are required for proper neuronal differentiation.
However, because DDX6 could nevertheless induce differ-
entiation in some TRIM32-deficient NSCs, it may possess
additional functionality, independent of TRIM32. This is
further supported by our observation that TRIM32 and
DDX6 colocalized to some, but not all, cytoplasmic punc-
tae. The loss ofDDX6 function, either by shRNAormutant
DDX6-EQ, resulted in a strong decrease in the amount of
TuJ1-positive neurons, alongwith an increase in the amount
of proliferating cells, suggesting that functional DDX6 is
required for neuronal differentiation. This effect was even
more pronounced in the absence of TRIM32, indicating
that both proteins cooperate during the induction of neu-
ronal differentiation in NSCs. To promote neuronal differ-
entiation, TRIM32 may recruit DDX6 to RISC and fa-
cilitate or stabilize its binding to the microRNA or target
mRNA. Additionally, TRIM32 may stimulate the helicase
activity of DDX6, leading to the unwinding of secondary
structures within the target mRNA or the remodeling of
RNA–protein complexes. Alternatively, DDX6 may bind
to the mRNA first and recruit TRIM32 into the complex.
However, because NSCs were still able to differentiate fol-
lowing the depletion of eitherDDX6 or TRIM32, both pro-
teins can also act independently of each other in promot-
ing neuronal differentiation. In future studies, it would be
interesting to map the interaction surfaces of DDX6 and
TRIM32 and to analyze the influence of abrogating their in-
teraction on miRNA activity and neuronal differentiation.
In summary, our results provide significant insights into
the regulation of microRNA-mediated neuronal differen-
tiation. We identified a set of novel candidate interaction
partners of TRIM32 during neuronal differentiation that
are associated with the regulation of RNA, including Ago2
and DDX6. Of these, the RNA helicase DDX6 was able
to efficiently induce neuronal differentiation in cooperation
with TRIM32 by increasing the activity of the microRNA
Let-7a.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
 at U
niversity of Luxem
bourg on M
arch 11, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
16 Nucleic Acids Research, 2015
ACKNOWLEDGMENTS
We thank Raymond Poot and Jeroen Demmers (Erasmus
MC, the Netherlands) for the protein identification by mass
spectrometry. We thank Dr Sven Diederichs, Dr Dirk H.
Ostareck, Dr Masayuki Matsushita and Dr Stanley M.
Lemon for plasmids as well as IngaWerthschulte, Thea van
Wu¨llen and Anna-Lena Benker for excellent technical as-
sistance. Figure 1 was produced using Servier Medical Art
(www.servier.com).
FUNDING
Mu¨nster Graduate Program for Cell Dynamics and Dis-
ease (CEDAD) (to S.N. and A.L.H.); Fonds National de la
Recherche (FNR) fellowships (AFR, Aides a` la Formation-
Recherche) (to L.G.C. and S.O.); German Research
Foundation [DFG SFB629 to J.C.S.]; Schram-Stiftung
[T287/21795/2011 to J.C.S.]; Boehringer Ingelheim Foun-
dation (to J.C.S.); Fonds National de la Recherche (FNR)
Luxembourg and a University Luxembourg Internal Re-
search Project (MidNSCs) (to J.C.S.); Innovative Medical
Research fund of theUniversity ofMu¨nsterMedical School
[SC120901, SC411003 to J.C.S.]. Funding for open access
charge: Institutes budget.
Conflict of interest statement.None declared.
REFERENCES
1. Gage,F.H. (2000) Mammalian neural stem cells. Science, 287,
1433–1438.
2. Gotz,M. and Huttner,W.B. (2005) The cell biology of neurogenesis.
Nat. Rev. Mol. Cell Biol., 6, 777–788.
3. Reynolds,B.A. and Weiss,S. (1992) Generation of neurons and
astrocytes from isolated cells of the adult mammalian central nervous
system. Science, 255, 1707–1710.
4. Goldman,S.A. and Nottebohm,F. (1983) Neuronal production,
migration, and differentiation in a vocal control nucleus of the adult
female canary brain. Proc. Natl. Acad. Sci. U.S.A., 80, 2390–2394.
5. Bunk,E.C., Stelzer,S., Hermann,S., Schafers,M., Schlatt,S. and
Schwamborn,J.C. (2011) Cellular organization of adult neurogenesis
in the Common Marmoset. Aging Cell, 10, 28–38.
6. Eriksson,P.S., Perfilieva,E., Bjork-Eriksson,T., Alborn,A.M.,
Nordborg,C., Peterson,D.A. and Gage,F.H. (1998) Neurogenesis in
the adult human hippocampus. Nat. Med., 4, 1313–1317.
7. Spalding,K.L., Bergmann,O., Alkass,K., Bernard,S., Salehpour,M.,
Huttner,H.B., Bostrom,E., Westerlund,I., Vial,C., Buchholz,B.A.
et al. (2013) Dynamics of hippocampal neurogenesis in adult humans.
Cell, 153, 1219–1227.
8. Ernst,A., Alkass,K., Bernard,S., Salehpour,M., Perl,S., Tisdale,J.,
Possnert,G., Druid,H. and Frisen,J. (2014) Neurogenesis in the
striatum of the adult human brain. Cell, 156, 1072–1083.
9. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism,
and function. Cell, 116, 281–297.
10. Winter,J., Jung,S., Keller,S., Gregory,R.I. and Diederichs,S. (2009)
Many roads to maturity: microRNA biogenesis pathways and their
regulation. Nat. Cell Biol., 11, 228–234.
11. Eulalio,A., Huntzinger,E. and Izaurralde,E. (2008) Getting to the
root of miRNA-mediated gene silencing. Cell, 132, 9–14.
12. Hammell,C.M. (2008) The microRNA-argonaute complex: a
platform for mRNA modulation. RNA Biol., 5, 123–127.
13. Bartel,D.P. (2009) MicroRNAs: target recognition and regulatory
functions. Cell, 136, 215–233.
14. Palm,T., Hemmer,K., Winter,J., Fricke,I.B., Tarbashevich,K.,
Sadeghi Shakib,F., Rudolph,I.M., Hillje,A.L., De Luca,P.,
Bahnassawy,L. et al. (2013) A systemic transcriptome analysis reveals
the regulation of neural stem cell maintenance by an E2F1-miRNA
feedback loop. Nucleic Acids Res., 41, 3699–3712.
15. Shi,Y., Zhao,X., Hsieh,J., Wichterle,H., Impey,S., Banerjee,S.,
Neveu,P. and Kosik,K.S. (2010) MicroRNA regulation of neural stem
cells and neurogenesis. J. Neurosci., 30, 14931–14936.
16. Coolen,M., Thieffry,D., Drivenes,O., Becker,T.S. and Bally-Cuif,L.
(2012) miR-9 controls the timing of neurogenesis through the direct
inhibition of antagonistic factors. Dev. Cell, 22, 1052–1064.
17. Sun,A.X., Crabtree,G.R. and Yoo,A.S. (2013) MicroRNAs:
regulators of neuronal fate. Curr. Opin. Cell Biol., 25, 215–221.
18. Maffioletti,E., Tardito,D., Gennarelli,M. and Bocchio-Chiavetto,L.
(2014) Micro spies from the brain to the periphery: new clues from
studies on microRNAs in neuropsychiatric disorders. Front. Cell.
Neurosci., 8, 75.
19. Palm,T., Bahnassawy,L. and Schwamborn,J. (2012) miRNAs and
neural stem cells: a team to treat Parkinson’s disease? RNA Biol., 9,
720–730.
20. Roush,S. and Slack,F.J. (2008) The let-7 family of microRNAs.
Trends Cell Biol., 18, 505–516.
21. Wulczyn,F.G., Smirnova,L., Rybak,A., Brandt,C., Kwidzinski,E.,
Ninnemann,O., Strehle,M., Seiler,A., Schumacher,S. and Nitsch,R.
(2007) Post-transcriptional regulation of the let-7 microRNA during
neural cell specification. FASEB J., 21, 415–426.
22. Schwamborn,J.C., Berezikov,E. and Knoblich,J.A. (2009) The
TRIM-NHL protein TRIM32 activates microRNAs and prevents
self-renewal in mouse neural progenitors. Cell, 136, 913–925.
23. Reymond,A., Meroni,G., Fantozzi,A., Merla,G., Cairo,S., Luzi,L.,
Riganelli,D., Zanaria,E., Messali,S., Cainarca,S. et al. (2001) The
tripartite motif family identifies cell compartments. EMBO J., 20,
2140–2151.
24. Napolitano,L.M. and Meroni,G. (2012) TRIM family: pleiotropy
and diversification through homomultimer and heteromultimer
formation. IUBMB Life, 64, 64–71.
25. Hillje,A.L., Worlitzer,M.M., Palm,T. and Schwamborn,J.C. (2011)
Neural stem cells maintain their stemness through protein kinase C
zeta-mediated inhibition of TRIM32. Stem Cells , 29, 1437–1447.
26. Gonzalez-Cano,L., Hillje,A.L., Fuertes-Alvarez,S., Marques,M.M.,
Blanch,A., Ian,R.W., Irwin,M.S., Schwamborn,J.C. and Marin,M.C.
(2013) Regulatory feedback loop between TP73 and TRIM32. Cell
Death Dis., 4, e704.
27. Hillje,A.L., Pavlou,M.A., Beckmann,E., Worlitzer,M.M.,
Bahnassawy,L., Lewejohann,L., Palm,T. and Schwamborn,J.C.
(2013) TRIM32-dependent transcription in adult neural progenitor
cells regulates neuronal differentiation. Cell Death Dis., 4, e976.
28. Nicklas,S., Otto,A., Wu,X., Miller,P., Stelzer,S., Wen,Y., Kuang,S.,
Wrogemann,K., Patel,K., Ding,H. et al. (2012) TRIM32 regulates
skeletal muscle stem cell differentiation and is necessary for normal
adult muscle regeneration. PLoS One, 7, e30445.
29. Napolitano,L.M., Jaffray,E.G., Hay,R.T. and Meroni,G. (2011)
Functional interactions between ubiquitin E2 enzymes and TRIM
proteins. Biochem. J., 434, 309–319.
30. Neumuller,R.A., Betschinger,J., Fischer,A., Bushati,N.,
Poernbacher,I., Mechtler,K., Cohen,S.M. and Knoblich,J.A. (2008)
Mei-P26 regulates microRNAs and cell growth in the Drosophila
ovarian stem cell lineage. Nature, 454, 241–245.
31. Hammell,C.M., Lubin,I., Boag,P.R., Blackwell,T.K. and Ambros,V.
(2009) nhl-2 Modulates microRNA activity in Caenorhabditis
elegans. Cell, 136, 926–938.
32. Loedige,I. and Filipowicz,W. (2009) TRIM-NHL proteins take on
miRNA regulation. Cell, 136, 818–820.
33. Navarro,R.E., Shim,E.Y., Kohara,Y., Singson,A. and Blackwell,T.K.
(2001) cgh-1, a conserved predicted RNA helicase required for
gametogenesis and protection from physiological germline apoptosis
in C. elegans. Development, 128, 3221–3232.
34. Weston,A. and Sommerville,J. (2006) Xp54 and related (DDX6-like)
RNA helicases: roles in messenger RNP assembly, translation
regulation and RNA degradation. Nucleic Acids Res., 34, 3082–3094.
35. Bolte,S. and Cordelieres,F.P. (2006) A guided tour into subcellular
colocalization analysis in light microscopy. J. microsc., 224, 213–232.
36. Diederichs,S., Jung,S., Rothenberg,S.M., Smolen,G.A., Mlody,B.G.
and Haber,D.A. (2008) Coexpression of Argonaute-2 enhances RNA
interference toward perfect match binding sites. Proc. Natl. Acad. Sci.
U.S.A., 105, 9284–9289.
37. Conti,L., Pollard,S.M., Gorba,T., Reitano,E., Toselli,M., Biella,G.,
Sun,Y., Sanzone,S., Ying,Q.L., Cattaneo,E. et al. (2005)
 at U
niversity of Luxem
bourg on M
arch 11, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015 17
Niche-independent symmetrical self-renewal of a mammalian tissue
stem cell. PLoS Biol., 3, e283.
38. van den Berg,D.L., Snoek,T., Mullin,N.P., Yates,A., Bezstarosti,K.,
Demmers,J., Chambers,I. and Poot,R.A. (2010) An Oct4-centered
protein interaction network in embryonic stem cells. Cell Stem Cell,
6, 369–381.
39. Wilm,M., Shevchenko,A., Houthaeve,T., Breit,S., Schweigerer,L.,
Fotsis,T. and Mann,M. (1996) Femtomole sequencing of proteins
from polyacrylamide gels by nano-electrospray mass spectrometry.
Nature, 379, 466–469.
40. Nikolsky,Y., Ekins,S., Nikolskaya,T. and Bugrim,A. (2005) A novel
method for generation of signature networks as biomarkers from
complex high throughput data. Toxicol. Lett., 158, 20–29.
41. Shannon,P., Markiel,A., Ozier,O., Baliga,N.S., Wang,J.T.,
Ramage,D., Amin,N., Schwikowski,B. and Ideker,T. (2003)
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res., 13, 2498–2504.
42. Kedde,M., van Kouwenhove,M., Zwart,W., Oude Vrielink,J.A.,
Elkon,R. and Agami,R. (2010) A Pumilio-induced RNA structure
switch in p27–3’ UTR controls miR-221 and miR-222 accessibility.
Nat. Cell Biol., 12, 1014–1020.
43. Sonoda,J. and Wharton,R.P. (2001) Drosophila Brain Tumor is a
translational repressor. Genes Dev., 15, 762–773.
44. Jangra,R.K., Yi,M. and Lemon,S.M. (2010) DDX6 (Rck/p54) is
required for efficient hepatitis C virus replication but not for internal
ribosome entry site-directed translation. J. Virol., 84, 6810–6824.
45. Cohen,S., Zhai,B., Gygi,S.P. and Goldberg,A.L. (2012)
Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands,
and thin filaments in muscle atrophy. J. Cell Biol., 198, 575–589.
46. Kudryashova,E., Kudryashov,D., Kramerova,I. and Spencer,M.J.
(2005) Trim32 is a ubiquitin ligase mutated in limb girdle muscular
dystrophy type 2H that binds to skeletal muscle myosin and
ubiquitinates actin. J. Mol. Biol., 354, 413–424.
47. Fridell,R.A., Harding,L.S., Bogerd,H.P. and Cullen,B.R. (1995)
Identification of a novel human zinc finger protein that specifically
interacts with the activation domain of lentiviral Tat proteins.
Virology, 209, 347–357.
48. Wulczyn,F.G., Cuevas,E., Franzoni,E. and Rybak,A. (2011) miRNAs
need a trim : regulation of miRNA activity by trim-NHL proteins.
Adv. Exp. Med. Biol., 700, 85–105.
49. Petri,S., Dueck,A., Lehmann,G., Putz,N., Rudel,S., Kremmer,E. and
Meister,G. (2011) Increased siRNA duplex stability correlates with
reduced off-target and elevated on-target effects. RNA, 17, 737–749.
50. Meister,G. (2013) Argonaute proteins: functional insights and
emerging roles. Nat. Rev. Genet., 14, 447–459.
51. Betschinger,J., Mechtler,K. and Knoblich,J.A. (2006) Asymmetric
segregation of the tumor suppressor brat regulates self-renewal in
Drosophila neural stem cells. Cell, 124, 1241–1253.
52. Sampson,V.B., Rong,N.H., Han,J., Yang,Q., Aris,V., Soteropoulos,P.,
Petrelli,N.J., Dunn,S.P. and Krueger,L.J. (2007) MicroRNA let-7a
down-regulates MYC and reverts MYC-induced growth in Burkitt
lymphoma cells. Cancer Res., 67, 9762–9770.
53. Bussing,I., Slack,F.J. and Grosshans,H. (2008) let-7 microRNAs in
development, stem cells and cancer. Trends Mol. Med., 14, 400–409.
54. Chu,C.Y. and Rana,T.M. (2006) Translation repression in human
cells by microRNA-induced gene silencing requires RCK/p54. PLoS
Biol., 4, e210.
55. Cordin,O., Banroques,J., Tanner,N.K. and Linder,P. (2006) The
DEAD-box protein family of RNA helicases. Gene, 367, 17–37.
56. Linder,P. and Jankowsky,E. (2011) From unwinding to
clamping––the DEAD box RNA helicase family. Nat. Rev. Mol. Cell
Biol., 12, 505–516.
57. Coller,J. and Parker,R. (2005) General translational repression by
activators of mRNA decapping. Cell, 122, 875–886.
58. Naarmann,I.S., Harnisch,C., Muller-Newen,G., Urlaub,H.,
Ostareck-Lederer,A. and Ostareck,D.H. (2010) DDX6 recruits
translational silenced human reticulocyte 15-lipoxygenase mRNA to
RNP granules. RNA, 16, 2189–2204.
59. Saito,K., Kondo,E. and Matsushita,M. (2011) MicroRNA 130 family
regulates the hypoxia response signal through the P-body protein
DDX6. Nucleic Acids Res., 39, 6086–6099.
60. Rouya,C., Siddiqui,N., Morita,M., Duchaine,T.F., Fabian,M.R. and
Sonenberg,N. (2014) Human DDX6 effects miRNA-mediated gene
silencing via direct binding to CNOT1. RNA, 20, 1398–1409.
61. Chen,Y., Boland,A., Kuzuoglu-Ozturk,D., Bawankar,P., Loh,B.,
Chang,C.T., Weichenrieder,O. and Izaurralde,E. (2014) A
DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal
direct links between miRNA target recognition and silencing.Mol.
Cell, 54, 737–750.
62. Mathys,H., Basquin,J., Ozgur,S., Czarnocki-Cieciura,M.,
Bonneau,F., Aartse,A., Dziembowski,A., Nowotny,M., Conti,E. and
Filipowicz,W. (2014) Structural and biochemical insights to the role
of the CCR4-NOT complex and DDX6 ATPase in microRNA
repression.Mol. Cell, 54, 751–765.
63. Sen,G.L. and Blau,H.M. (2005) Argonaute 2/RISC resides in sites of
mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell
Biol., 7, 633–636.
64. Liu,J., Valencia-Sanchez,M.A., Hannon,G.J. and Parker,R. (2005)
MicroRNA-dependent localization of targeted mRNAs to
mammalian P-bodies. Nat. Cell Biol., 7, 719–723.
65. Pillai,R.S., Bhattacharyya,S.N., Artus,C.G., Zoller,T., Cougot,N.,
Basyuk,E., Bertrand,E. and Filipowicz,W. (2005) Inhibition of
translational initiation by Let-7 MicroRNA in human cells. Science,
309, 1573–1576.
 at U
niversity of Luxem
bourg on M
arch 11, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
